Phase II Pilot: SCRT – hypofractionated radiation for high-risk cSCC local control

This Phase II trial evaluates whether five-fraction SCRT offers effective local control for adults with head and neck cutaneous squamous cell carcinoma and if active surveillance is a safe alternative in moderate-risk patients. Sponsored by University of Vermont Medical Center, the study compares treatment outcomes against historical data to inform future adjuvant therapy approaches.